OFFICE OF FISCAL ANALYSIS

Legislative Office Building, Room 5200

Hartford, CT 06106 (860) 240-0200

http://www.cga.ct.gov/ofa

sHB-6856

AN ACT CONCERNING SUBSTANCE ABUSE AND OPIOID OVERDOSE PREVENTION.

AMENDMENT

LCO No.: 8387

File Copy No.: 583

House Calendar No.: 373


OFA Fiscal Note

State Impact:

Agency Affected

Fund-Effect

FY 16 $

FY 17 $

Consumer Protection, Dept.

GF - Eliminates Cost in Bill

187,511

187,511

Comptroller Misc. Accounts (Fringe Benefits)1

GF - Eliminates Cost in Bill

18,363

18,363

Consumer Protection, Dept.

GOBonds - Eliminates Cost in Bill

126,000

None

Note: GF=General Fund; GOBonds=General Obligation Bonds

Municipal Impact: None

Explanation

The amendment eliminates costs to the state in FY 16 of $331,874 and $205,874 in FY 17 associated with increased usage and reporting required in the underlying bill through the Prescription Monitoring Program (PMP).

The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely for the purposes of information, summarization and explanation and does not represent the intent of the General Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of informational sources, including the analyst's professional knowledge. Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.

1 The fringe benefit costs for most state employees are budgeted centrally in accounts administered by the Comptroller. The estimated active employee fringe benefit cost associated with most personnel changes is 38.65% of payroll in FY 16 and FY 17.